CZ20012041A3 - Benzofuranové deriváty - Google Patents
Benzofuranové derivátyInfo
- Publication number
- CZ20012041A3 CZ20012041A3 CZ20012041A CZ20012041A CZ20012041A3 CZ 20012041 A3 CZ20012041 A3 CZ 20012041A3 CZ 20012041 A CZ20012041 A CZ 20012041A CZ 20012041 A CZ20012041 A CZ 20012041A CZ 20012041 A3 CZ20012041 A3 CZ 20012041A3
- Authority
- CZ
- Czechia
- Prior art keywords
- benzofuran derivatives
- benzofuran
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11136098P | 1998-12-08 | 1998-12-08 | |
DKPA199801631 | 1998-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ20012041A3 true CZ20012041A3 (cs) | 2001-10-17 |
Family
ID=43768792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ20012041A CZ20012041A3 (cs) | 1998-12-08 | 1999-12-03 | Benzofuranové deriváty |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1137644B9 (cs) |
JP (1) | JP2002531556A (cs) |
AR (1) | AR021509A1 (cs) |
AT (1) | ATE249451T1 (cs) |
AU (1) | AU759248B2 (cs) |
CA (1) | CA2353618A1 (cs) |
CZ (1) | CZ20012041A3 (cs) |
DE (1) | DE69911243T2 (cs) |
DK (1) | DK1137644T3 (cs) |
ES (1) | ES2204175T3 (cs) |
HU (1) | HUP0104510A3 (cs) |
IL (1) | IL143082A (cs) |
ME (1) | MEP38508A (cs) |
PT (1) | PT1137644E (cs) |
RS (1) | RS50065B (cs) |
SE (1) | SE1137644T5 (cs) |
SI (1) | SI1137644T1 (cs) |
WO (1) | WO2000034263A1 (cs) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
EA008372B1 (ru) * | 2000-07-07 | 2007-04-27 | Х.Лундбекк А/С | Применение эсциталопрама для лечения расстройства, связанного с социальной тревогой |
EA008373B1 (ru) * | 2000-07-07 | 2007-04-27 | Х. Лундбекк А/С | Применение эсциталопрама для лечения расстройства, связанного с посттравматическим стрессом |
NZ523720A (en) * | 2000-07-21 | 2004-07-30 | H | Novel compounds and their use as glycine transport inhibitors |
AU2001288605A1 (en) * | 2000-09-06 | 2002-03-22 | Chugai Seiyaku Kabushiki Kaisha | A traceless solid-phase synthesis of 2-imidazolones |
US7235569B2 (en) | 2003-05-02 | 2007-06-26 | Wyeth | Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use |
US7276603B2 (en) | 2003-05-02 | 2007-10-02 | Wyeth | Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
US9394285B2 (en) | 2013-03-15 | 2016-07-19 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1143703A (cs) * | 1965-03-18 | |||
GB1173312A (en) * | 1966-03-17 | 1969-12-10 | Kefalas As | Heterocyclic Compounds |
GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
AU684874B2 (en) * | 1993-12-28 | 1998-01-08 | Pharmacia & Upjohn Company | Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
ZA954689B (en) * | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines |
-
1999
- 1999-12-01 AR ARP990106110A patent/AR021509A1/es unknown
- 1999-12-03 ME MEP-385/08A patent/MEP38508A/xx unknown
- 1999-12-03 SI SI9930412T patent/SI1137644T1/xx unknown
- 1999-12-03 ES ES99957263T patent/ES2204175T3/es not_active Expired - Lifetime
- 1999-12-03 SE SE99957263T patent/SE1137644T5/xx unknown
- 1999-12-03 RS YUP-384/01A patent/RS50065B/sr unknown
- 1999-12-03 WO PCT/DK1999/000676 patent/WO2000034263A1/en active IP Right Grant
- 1999-12-03 AT AT99957263T patent/ATE249451T1/de not_active IP Right Cessation
- 1999-12-03 HU HU0104510A patent/HUP0104510A3/hu unknown
- 1999-12-03 IL IL14308299A patent/IL143082A/en not_active IP Right Cessation
- 1999-12-03 JP JP2000586710A patent/JP2002531556A/ja active Pending
- 1999-12-03 DE DE69911243T patent/DE69911243T2/de not_active Expired - Fee Related
- 1999-12-03 CZ CZ20012041A patent/CZ20012041A3/cs unknown
- 1999-12-03 DK DK99957263T patent/DK1137644T3/da active
- 1999-12-03 CA CA002353618A patent/CA2353618A1/en not_active Abandoned
- 1999-12-03 PT PT99957263T patent/PT1137644E/pt unknown
- 1999-12-03 EP EP99957263A patent/EP1137644B9/en not_active Expired - Lifetime
- 1999-12-03 AU AU15036/00A patent/AU759248B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP1137644B9 (en) | 2004-03-17 |
RS50065B (sr) | 2009-01-22 |
CA2353618A1 (en) | 2000-06-15 |
SE1137644T5 (cs) | 2004-05-11 |
JP2002531556A (ja) | 2002-09-24 |
ES2204175T3 (es) | 2004-04-16 |
EP1137644B1 (en) | 2003-09-10 |
PT1137644E (pt) | 2004-01-30 |
IL143082A (en) | 2004-06-20 |
AU1503600A (en) | 2000-06-26 |
SE1137644T3 (cs) | 2003-12-02 |
HUP0104510A3 (en) | 2003-01-28 |
DK1137644T3 (da) | 2003-12-08 |
AR021509A1 (es) | 2002-07-24 |
SI1137644T1 (en) | 2003-12-31 |
YU38401A (sh) | 2005-06-10 |
MEP38508A (en) | 2011-02-10 |
DE69911243T2 (de) | 2004-07-15 |
AU759248B2 (en) | 2003-04-10 |
EP1137644A1 (en) | 2001-10-04 |
WO2000034263A1 (en) | 2000-06-15 |
IL143082A0 (en) | 2002-04-21 |
HUP0104510A2 (hu) | 2002-04-29 |
DE69911243D1 (de) | 2003-10-16 |
ATE249451T1 (de) | 2003-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL141226A0 (en) | 1h-imidazopyridine derivatives | |
PL345540A1 (en) | Thiobenzimidazole derivatives | |
HU9900120D0 (en) | Benzosulfone derivatives | |
PL334847A1 (en) | Substituted 3-heterocyclyl-benzoyl derivatives | |
GB9910384D0 (en) | Alpha-ketoamide derivatives | |
IL139808A0 (en) | Novel benzopyran or thiobenzopyran derivatives | |
IL135073A0 (en) | Substituted chroman derivatives | |
IL135074A0 (en) | Substituted chroman derivatives | |
ZA991550B (en) | Cyclohexanediole derivatives. | |
EG23802A (en) | 2-Phenylpyran-4-one derivatives | |
PL348191A1 (en) | Chroman derivatives | |
CZ20012041A3 (cs) | Benzofuranové deriváty | |
GB9816729D0 (en) | Substituted cyclohexylaminopyrimidines | |
HK1039937A1 (zh) | 取代的3-硫代氨基甲酰基吡唑類化合物 | |
PL347397A1 (en) | Substituted 3-aryl-pyrazoles | |
IL147494A0 (en) | Benzofuran derivatives | |
GB9827729D0 (en) | Thieno-indole derivatives | |
HUP0102476A3 (en) | Substituted cyclooctadepsipeptides | |
HK1039335A1 (zh) | 取代的苯甲酰基環已二酮類化合物 | |
EP1061912A4 (en) | PHENANTHROFURANDERIVATE | |
AU2641299A (en) | Benzofuran derivatives | |
IL139276A0 (en) | Cyclohexenondioxthio chromanoyl derivatives | |
AU2049601A (en) | Benzofuran derivatives | |
HK1042478A1 (zh) | 2-氧代-2h-喹啉衍生物 | |
GB9809109D0 (en) | Lactone |